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Antibodies specific for histone post-translational modifications (PTMs) have been central to our
understanding of chromatin biology. Here, we describe an unexpected and novel property of histone H4
site-specific acetyl antibodies in that they prefer poly-acetylated histone substrates. By all current criteria,
these antibodies have passed specificity standards. However, we find these site-specific histone antibodies
preferentially recognize chromatin signatures containing two or more adjacent acetylated lysines.
Significantly, we find that the poly-acetylated epitopes these antibodies prefer are evolutionarily conserved
andarepresentatlevelsthatcompetefortheseantibodiesovertheintendedindividualacetylationsites.This
alarming property of acetyl-specific antibodies has far-reaching implications for data interpretation and
may present a challenge for the future study of acetylated histone and non-histone proteins.
T
he identification and biological characterization of histone post-translational modifications (PTMs) has
been the subject of intense recent investigation
1–3. One of the most studied histone PTMs is lysine acetyla-
tion, which typically occurs on the N-terminal ‘‘tails’’ and globular domains of histones and can influence
chromatin-basedeventsincludingtranscription,DNAreplication,DNArepair,anddosagecompensation
1,4.One
mechanismbywhichlysineacetylationinfluenceschromatinfunctionisbyremovingpositivechargesfromlysine
side chains, thus making local chromatin structure more permissive to specific protein machineries
5. Lysine
acetylation can also function by serving as a docking site for bromodomain-containing proteins, often found as
subunits of histone acetyltransferases (HATs), ATP-dependent chromatin remodelers, and transcriptional coac-
tivators
6,7. Significantly, recent studies show that bromodomain-containing proteins preferentially recognize
poly-acetylated chromatin signatures
7–9. These studies lend further support to the ‘histone code’ hypothesis,
which suggests that histone PTMs function in a combinatorial fashion to regulate chromatin architecture and
DNA-templated cellular processes
10,11.
Direct investigations of biological functions associated with specific histone PTMs have been facilitated by
genetic and biochemical methods, and often depend on antibodies to monitor these PTMs. Furthermore, large
scale epigenomics efforts, like the ENCODE and modENCODE projects, rely on these antibodies to map the
genomic distribution of chromatin signatures
12–14. Therefore, antibody specificity is of utmost importance for
accurate data interpretation. The standard criteria for characterizing antibody specificity typically involves
primary reactivity with a single species from cell extracts by immunoblotting that is diminished in the absence
or mutation of epitope, and that can be competed with recombinant or synthetic antigen
17,22. Extended criteria
often involve characterizing the ability of antibodies to perform in biological assays, like chromatin immuno-
precipitation (ChIP),immunohistochemistry, enzyme-linkedimmunosorbent assay(ELISA),andimmunoblots.
Recent studies from our lab and others demonstrate that neighboring PTMs often enhance or perturb the
ability of histone antibodies to recognize their intended target
9,15,16. Furthermore, these studies have found that
histone antibodies often have specific difficulties in recognizing their appropriate epitopes, either due to the
inability to distinguish methyl-lysine states (mono-, di-, and tri-methylation)or to recognize off-target PTMs. In
addition, studies from the modENCODE consortium have found that . 25% of commercial histone antibodies
fail basic quality control measures
17. Here, we uncover a novel property of histone H4 antibody-antigen recog-
nition(preferentialdetectionofpoly-acetylatedchromatinsignatures)thatpresentsasignificantconcernwiththe
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SCIENTIFIC REPORTS | 2 : 489 | DOI: 10.1038/srep00489 1use of these reagents. Our findings caution interpreting results to
date that employ these site-specific acetyl antibodies and suggest
more thorough validation of antibodies is needed before they can
be labeled as specific.
Results
Site-specific H4 acetyl antibodies prefer poly-acetylated sub-
strates. To interrogate the interactions of chromatin-associated
proteins and antibodies with combinatorial histone PTMs, we
recently developed a peptide microarray platform where . 250
unique biotinylated histone peptides, containing 0–8 possible
PTMs, were immobilized on streptavidin-coated glass slides
(Supplemental Table 1)
9,16. These peptide arrays were probed with
a number of commonly used commercial histone acetyl-specific
antibodies (Supplemental Table 2) to discern their specificities. We
found that acetyl-specific antibodies directed against H3 lysines 9
and 14 (H3K9ac and H3K14ac) generally performed as expected,
in that they showed no discernable interaction with unmodified
histones, and detected their intended PTM alone and in the
context of adjacent acetylation events with similar signal intensity
(Fig. 1a and Supplemental Fig. 1). Of note, H3S10 phosphorylation
(H3S10p) perturbed the recognition of H3K9ac (see peptides 37, 41,
144,and148inSupplementalFig.1),buthadlittleeffectonH3K14ac
recognition. H3S10p, enriched on mitotic chromatin
18, has been
shown to exist on the same histone tail as H3K9ac in cells
19–21. Our
array analysis therefore suggests this H3S10 phosphorylated
population of H3K9 acetylated histone tails may be underre-
presented in biological assays using this antibody. We also detected
weakcross-reactivityoftheseantibodieswithH4andH2Aacetylated
peptides (Supplemental Fig. 1).
In sharp contrast to above, antibodies designed to recognize
H4K5ac, H4K8ac, and H4K12ac preferentially bound H4 peptides
harboring two or more adjacent acetylation events (Fig. 1b and
Supplemental Table2).Importantly,acetylrecognitionwasdepend-
entonthesingleacetylationeventthatwasintendedtoberecognized
by the antibody. For example, the H4K8ac antibody bound to
H4K8ac/K12ac and H4K8ac/K16ac, but not to the H4K12ac/K16ac
peptide(Fig.1b).SimilarobservationswereobservedfortheH4K5ac
andH4K12acantibodies.While poly-acetylatedsubstratesranked as
being the preferred substrates on our arrays for the H4 acetyl anti-
bodiestested(Fig.1bandSupplemental Table2),closerexamination
of the individually acetylated peptides revealed low-intensity (i.e.
weaker) interactions that demonstrated these antibodies do indeed
Table 1 | Antibody preference for tetra-acetyl epitopes
Antibody tetra-acetyl/mono-acetyl (6 s.e.m.)
H3K9ac 1.8 6 0.3
H3K14ac 1.1 6 0.2
H4K5ac 4.0 6 0.3
H4K8ac 21.9 6 5.0
H4K12ac 18.6 6 2.1
H4K16ac 1.7 6 0.3
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Figure 1 | (a-c) Heat maps summarizing peptide array results for H3 and H4 acetyl antibodies. For each array, the most intense series of peptide spots
(12 individual spots per peptide) is assigned a value of 1 (blue), and all values are normalized to this peptide. Values $ 0.1 are colored red in panel C to
enable interpretation of low signal intensities. Each interaction is presented as an averaged normalized intensity from at least two independent arrays
(r
2.0.9).SeeRothbartetal
16fordetails ofthearraymethodology. AntibodyinformationcanbefoundinSupplementalTable2.Whileoneantibodyfor
each histone PTM is shown in the figure for representation, other antibodies tested to the same PTMs showed similar findings (Supplemental Table 2).
(d)Normalizedarray signalintensities forH4K12ac antibody bindingtotheindicatedpeptides.Values arepresentedasanaverage of24individualspots
(2 arrays) 6 s.e.m.
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tion events on the H4 tail (Fig. 1c). By these criteria, these antibodies
would likely be labeled as specific. However, strong preference for
poly-acetylated peptides (4- to 20-fold; Table 1 and Supplemental
Table 2) suggests an added layer of complexity to the specificity
criteria and implies these antibodies may have difficulty distinguish-
ing singly modified epitopes in vivo. Importantly, the antibody we
tested that recognizes H416ac was not dramatically influenced by
poly-acetylated H4. However, unlike the other site-specific H4 anti-
bodies examined, the H4K16ac antibody cross-reacted with acety-
lated H3 and H2A peptides (Supplemental Fig. 2).
As acetylation masks the positive charge on lysine e-amines, we
next wondered if poly-acetyl recognition might be a consequence of
‘‘charge masking.’’ To test this idea, we synthesized an H4K12ac
peptide in which lysines 5, 8, and 16 were mutated to glutamine, a
commonly used acetyl mimic. Importantly, H4K12ac antibody
recognition of this peptide did not mimic that seen with a tetra-
acetylated peptide (Fig. 1d). These results strongly suggest poly-
acetyl antibody recognition is not solely a property of charge
neutralization.
Poly-acetylated chromatin signatures are evolutionarily con-
served. Our array results suggest that poly-acetylated H4 chro-
matin signatures could be problematic for antibody-based
detection of single H4 acetylation events in cells. However, the
extent to which poly-acetylated H4 chromatin signatures exist in
relation single acetylation events in cells is unknown. We therefore
sought to determine and compare the abundance of histone H4
acetylation signatures by mass spectrometry in budding yeast,
mouse embryonic stem cells (mESCs), mouse embryonic fib-
roblasts (MEFs), and the HeLa human cervical carcinoma cell line
(Fig.2aandSupplementalFig.3).Inallfourcelltypes,50–60%ofthe
H4 tail (residues 4–17) is unmodified, while H4K16ac marks 20–
40%. H4K12ac is the next most abundant single mark (5–15%) in
all cells analyzed, followed by H4K5ac (,5%) and the H4K8ac
(,2%). Importantly, the presence of poly-acetylation events (i.e.
two or more) on the H4 tail is detectable in all cells examined, and
this signature is often present at levels comparable to both H4K5ac
and H4K8ac as single acetylation events (Fig 2a).
Site-specific H4 acetyl antibodies preferentially recognize poly-
acetylation signatures in bulk chromatin. The biological iden-
tification of appreciable poly-acetylated H4 finally led us to
determine whether site-specific H4 acetyl antibodies preferentially
recognize this poly-acetylated chromatin signature in cells. Using
peptide competition assays, we first examined the H4K12ac
antibody, which showed a strong (20-fold) preference for poly-
acetylated peptides over the single mark by array (Table 1), but
conversely was under-represented as a poly-acetylated chromatin
signature in vivo in comparison to the single mark by mass
spectrometry (Fig 2a). Importantly, a tetra-acetylated H4 peptide
was able to compete the H4K12ac antibody at a concentration 10-
fold lower than an H4K12ac peptide (Fig 2b). Similar results were
seen with an H4K5ac antibody (Fig 2c). Collectively, these results
demonstrate that poly-acetylation signatures are prevalent in cells
and are the preferred epitope for these site-specific acetyl antibodies.
Discussion
Selectivity issues related to antibodies, especially those targeting his-
tone PTMs, is by no means a new problem. Common concerns
include cross-reactivity with other PTMs or states of methyl-lysine,
andrecentstudieshavebeguncharacterizinghowneighboringPTMs
influence antibody recognition in a similar manner to effector pro-
tein binding
9,15,16,22. With so many biological methods relying on
single acetyl poly acetyl GKGGKGLGKGGAKR
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Figure 2 | (a) Quantitative mass spectrometry to determine the distribution of single- and poly-acetylation of the indicated H4 peptide across species.
Poly-ac is represented as a summation of 2 or more acetylations in the context of the single mark. A complete analysis is shown in Supplemental Fig. 3.
(b-c) Western blots of HeLa chromatin extracts following antibody incubation with the indicated concentrations of competing peptide.
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ofthesereagentsisparamount.Ourresultsdemonstrateapreviously
uncharacterized property of histone H4 site-specific acetyl antibod-
ies, an inherent preference for poly-acetylated chromatin signatures.
By standard criteria, these antibodies would be judged selective for
their intended PTM. They all recognize a single protein band by
immunoblot, can be competed with a peptide antigen, do not
cross-react with other singly acetylated epitopes, and even have been
shown to lose reactivity when probing for histones mutated at the
targetlysine(Figs.1–2anddatanotshown).Usingourpeptidearrays
asanew criterionforantibodycharacterization, our findingssuggest
H4K5ac, H4K8ac and H4K12ac antibodies may not recognize their
intended target, but instead, all recognize the same poly-acetylated
histone signature.
Our unexpected finding regarding the property of H4 acetyl-spe-
cific antibodies raises new questions with the interpretation of
genome-wide mapping studies of H4 acetylation events across spe-
cies and cell lines. In general, genomic studies find ahigh correlation
for the positioning of H4K5ac, K8ac, and K12ac across genomes
23–25.
However, it is entirely possible that these findings represent the
preference of these antibodies for H4 poly-acetylation – a chromatin
signature that is present in vivo and at levels that these antibodies
would compete for over their individually acetylated counterparts.
Given the problematic nature of these antibodies, the true genomic
locations and relative distributions of the individual H4K45ac,
H4K8acandH4K12acmarksarelikelystillunknown.Sinceourmass
spectrometry results show high species conservation and significant
abundance of singly acetylated H4 tails, we suggest that the indi-
vidual H4K5, H4K8 and H4K12 acetylation events might have
non-overlapping genomic distributions and functions. Future stud-
ies involving improved site-specific H4 acetyl antibodies will be
needed to test this hypothesis.
A counter argument to the concern of recognizing poly-acetyla-
tion signatures are classic genetic studies in budding yeast showing
that mutation of H4 lysines 5, 8, and 12 individually have indistin-
guishable changes in gene expression profiles or growth defects,
while only mutation of lysine 16 has a unique gene expression sig-
nature
23,26.CombingmultipleH4lysinemutationsresultsinacumu-
lative effect on gene expression and defective growth - suggesting
H4K5,H4K8andH4K12acetylationeventsarefunctionallyredund-
ant and cumulative. However, parallel studies have not yet been
performed in more complex organisms where individual acetylation
events might play a more significant role. With a new Drosophila
melanogaster histone replacement model now available, important
and interesting questions such as these can be tested
27.
One question remaining is why might these antibodies strongly
detect poly-acetylated histones in the first place? The fact that H3
acetyl antibodies do not have strong poly-acetyl preference suggests
this problem is specific towards histone H4. A potential explanation
may lie in the repetitive sequence surrounding the K5, K8 and K12
acetylation sites on the H4 tail. The GKG motif that surrounds these
lysines is repeated on the histone H4 tail. Lysine 16, however, differs,
fromthispattern(AKR),andtheH4K16acantibodycoincidentlyhas
the least enhanced preference for poly-acetylated H4. Regardless of
the reasons, one would ideally want the H4 acetyl antibodies to
behavemoresimilarlytotheH3acetylantibodiestested,recognizing
singly modified acetyl-lysines similarly to poly-acetylated epitopes.
Beyond histones, we note that high-resolution mass spectrometry
studies have recently identified thousands of acetylation events across
multiple species
28–31. Site-specific acetyl antibodies will undoubtedly be
developed for studying biological functions associated with these non-
histone acetylation events. Importantly, the same GKG consensus
motif that may pose a problem for H4 acetyl antibodies surrounds a
number of identified acetylated lysines on non-histone proteins
32,33.I t
remains to be determined whether similar antibody-based detection
issues will apply for these non-histone PTMs.
In conclusion, we describe a new and concerning property of site-
specific acetyl antibodies that has been previously missed in all other
forms of characterization. This re-defined property has implications
forpastdatainterpretationandrepresentsaformidablechallengefor
future studies. This paper therefore serves to encourage more thor-
ough validation of the next generation of acetyl antibodies for the
biological community at large.
Methods
Materials.AfulllistofantibodiesusedinthisstudyisavailableinSupplementalTable
2. HeLa cells were cultured in suspension between 5210 3 10
5 cells/ml in minimum
essential Joklik modified media supplemented with 10% new-born calf serum, 2 mM
L-glutamine, 100 units/mL penicillin, and 0.1 mg/mL streptomycin
34. mESCs were
culturedinDMEMhighglucosemediumsupplementedwith15%fetalbovineserum,
2 mML-glutamine,0.1 mMnon-essential amino acids, 0.1 mM 2-mercaptoethanol,
100 units/mL penicillin, 0.1 mg/mL streptomycin/mL, and 1000 units/mL LIF/
ESGRO
35. MEFs were derived from 14.5 d mouse embryos and cultured in DMEM
high glucose medium supplemented with 10% fetal bovine serum, 2 mM
L-Glutamine, 100 units/mL penicillin, and 0.1 mg/mL streptomycin
35.
Peptide arrays. Peptide synthesis and validation, array fabrication, and antibody
analysis were performed essentially as described
9,16.
Mass spectrometry. Sample collection, derivation, and mass spectrometry were
performed as previously described
34 with the following modifications: 60 to 120 mg
bulk histones were used for each chemical derivation and analysis; the m/z of double,
triple and quadruple acetylations on the H4 4–17 peptide were targeted in the MS
runs.
Peptide competitions. Bulk chromatin was isolated from asynchronously growing
HeLacells asdescribed
36withthe followingmodifications:Pelletedcells werelysedin
cold buffer containing 10 mM PIPES, pH 7.0, 300 mM sucrose, 100 mM NaCl,
3 mM MgCl2, 1x EDTA-free protease inhibitor (Roche), 1x phosphatase inhibitor
cocktail (Sigma), and 0.1% Triton X-100. Chromatin fractions were treated with
benzonase to solubilize histones prior to SDS-PAGE.
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